Regulacje i polityka gospodarcza · 13/09/2021
National Cancer Institute to Grant Exclusive Patent License to Athenex for Cancer Cell Therapies
The National Cancer Institute is considering granting an exclusive patent license to Athenex, Inc. for the development and commercialization of cell therapies for cancer.